Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Parisa Hasanein, Rosa Seifi, Mohammad Reza Hajinezhad & Abbasali Emamjomeh. (2017) Rosmarinic acid protects against chronic ethanol-induced learning and memory deficits in rats. Nutritional Neuroscience 20:9, pages 547-554.
Read now
Read now
Alberto Halabe Bucay. (2009) Donepezil (aricept) as a treatment for anorexia nervosa: a very feasible therapeutic possibility. Expert Opinion on Investigational Drugs 18:5, pages 569-571.
Read now
Read now
Ben Seltzer. (2007) Donepezil: an update. Expert Opinion on Pharmacotherapy 8:7, pages 1011-1023.
Read now
Read now
Maria Laura Bolognesi, Anna Minarini, Vincenzo Tumiatti & Carlo Melchiorre. (2006) Progress in acetylcholinesterase inhibitors for Alzheimer’s disease. Expert Opinion on Therapeutic Patents 16:6, pages 811-823.
Read now
Read now
Articles from other publishers (31)
Weilin Liu, Jianhong Li, Minguang Yang, Xiaohua Ke, Yaling Dai, Huawei Lin, Sinuo Wang, Lidian Chen & Jing Tao. (2022) Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer’s disease. Alzheimer's Research & Therapy 14:1.
Crossref
Crossref
Robert R. Redman, Harry Mackenzie, Kosala N. Dissanayake, Michael Eddleston & Richard R. Ribchester. (2022) Donepezil inhibits neuromuscular junctional acetylcholinesterase and enhances synaptic transmission and function in isolated skeletal muscle. British Journal of Pharmacology 179:24, pages 5273-5289.
Crossref
Crossref
Tarek Zieneldien, Janice Kim, Darrell Sawmiller & Chuanhai Cao. (2022) The Immune System as a Therapeutic Target for Alzheimer’s Disease. Life 12:9, pages 1440.
Crossref
Crossref
Zafer Sahin, Sevde Nur Biltekin, Leyla Yurttaş, Barkin Berk, Tuba Tüylü Küçükkılınç & Şeref Demirayak. (2022) Novel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors. Journal of Molecular Structure 1264, pages 133193.
Crossref
Crossref
Jee Hyun Yi, Somin Moon, Eunbi Cho, Huiyoung Kwon, Seungjin Lee, Jieun Jeon, A Young Park, Ye Hee Lee, Kyoung Ja Kwon, Jong Hoon Ryu, Se Jin Jeon, Chan Young Shin, Sang Hee Shim & Dong Hyun Kim. (2022) Hyperoside improves learning and memory deficits by amyloid β1-42 in mice through regulating synaptic calcium-permeable AMPA receptors. European Journal of Pharmacology 931, pages 175188.
Crossref
Crossref
Lucía Torres-Simón, Sandra Doval, Alberto Nebreda, Sophia J. Llinas, Elisabeth B. Marsh & Fernando Maestú. (2022) Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review. NeuroImage: Clinical 35, pages 103040.
Crossref
Crossref
Elham Zarean, Morteza Sedehi & Yalda Heshmati. (2021) Efficacy of Donepezil in Improving Cognitive Impairment Induced by Electroconvulsive Therapy in Patients with Mood Disorders: A Randomized, Double-blind, Placebo-Controlled Trial. Iranian Journal of Psychiatry and Behavioral Sciences 15:3.
Crossref
Crossref
Jan Bures, Ilja Tacheci, Jaroslav Kvetina, Vera Radochova, Lukas Prchal, Darina Kohoutova, Martin Valis, Martin Novak, Rafael Dolezal, Marcela Kopacova, Stanislav Rejchrt, Vit Sestak, Veronika Knoblochova, Eva Peterova & Jana Zdarova Karasova. (2021) The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs. Molecules 26:8, pages 2160.
Crossref
Crossref
Song Yi Lee, Ju-Hwan Park, Mingyu Yang, Min-Jun Baek, Min-Hwan Kim, Junmin Lee, Ali Khademhosseini, Dae-Duk Kim & Hyun-Jong Cho. (2020) Ferrous sulfate-directed dual-cross-linked hyaluronic acid hydrogels with long-term delivery of donepezil. International Journal of Pharmaceutics 582, pages 119309.
Crossref
Crossref
Narges Shams-Alizadeh, Azad Maroufi, Akbar Qanbarzadeh Chelan Sofla, Ebrahim Ghaderi & Kambiz Hassanzadeh. (2019) Effect of Donepezil on Cognitive Deficits Associated With Electroconvulsive Therapy: A Randomized Triple-blind Clinical Trial. Clinical Neuropharmacology 42:2, pages 27-31.
Crossref
Crossref
Jonathan L. Melamed, Fernando M. de Jesus, Rafael S. Maior & Marilia Barros. (2017) Scopolamine Induces Deficits in Spontaneous Object-Location Recognition and Fear-Learning in Marmoset Monkeys. Frontiers in Pharmacology 8.
Crossref
Crossref
Jun Yan, Jinhui Hu, Anqiu Liu, Lin He, Xingshu Li & Hui Wei. (2017) Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer’s disease based on the fusion of donepezil and curcumin. Bioorganic & Medicinal Chemistry 25:12, pages 2946-2955.
Crossref
Crossref
Sang-Ho Kim, Dae-Kyoo Chung, Young Joon Lee, Chang-Hyun Song & Sae-Kwang Ku. (2016) Neuroprotective effects of Danggui-Jakyak-San on rat stroke model through antioxidant/antiapoptotic pathway. Journal of Ethnopharmacology 188, pages 123-133.
Crossref
Crossref
Kyung-Seok Lee & Dae-Kyoo Chung. (2015) Sungshim-san-mediated Recovery of Cognition and Motor Function in the Severe Rat Stroke, Permanent Middle Cerebral Artery Occlusion Model. Journal of Oriental Neuropsychiatry 26:3, pages 319-336.
Crossref
Crossref
Parisa Hasanein & Azam Kazemian Mahtaj. (2015) Ameliorative effect of rosmarinic acid on scopolamine-induced memory impairment in rats. Neuroscience Letters 585, pages 23-27.
Crossref
Crossref
Paul A. Howard-Jones & Kate D. Fenton. (2011) The Need for Interdisciplinary Dialogue in Developing Ethical Approaches to Neuroeducational Research. Neuroethics 5:2, pages 119-134.
Crossref
Crossref
Ümide Demir Özkay, Özgür Devrim Can, Yusuf Özkay & Yusuf Öztürk. (2012) Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits. Pharmacological Reports 64:4, pages 834-847.
Crossref
Crossref
Cesare Mancuso, Raffaella Siciliano, Eugenio Barone & Paolo Preziosi. (2012) Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:5, pages 616-624.
Crossref
Crossref
William Cho, Paul Maruff, John Connell, Cindy Gargano, Nicole Calder, Scott Doran, Sabrina Fox-Bosetti, Aizza Hassan, John Renger, Gary Herman, Christopher Lines & Ajay Verma. (2011) Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans. Psychopharmacology 218:3, pages 513-524.
Crossref
Crossref
Shahin Akhondzadeh, Maryam Gerami, Maryam Noroozian, Narges Karamghadiri, Aboulfazl Ghoreishi, Seyed-Hesameddin Abbasi & Sams-Ali Rezazadeh. (2008) A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:8, pages 1810-1815.
Crossref
Crossref
Jerry J. Buccafusco, Alvin V. TerryJrJr, Scott J. Webster, Daniel Martin, Elizabeth J. Hohnadel, Kristy A. Bouchard & Samantha E. Warner. (2007) The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology 199:3, pages 481-494.
Crossref
Crossref
A. Marighetto, S. Valerio, A. Desmedt, J. N. Philippin, C. Trocmé-Thibierge & P. Morain. (2008) Comparative effects of the α7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice. Psychopharmacology 197:3, pages 499-508.
Crossref
Crossref
Gustavo C. Román. 2008. Dementias. Dementias
639
658
.
AiLin Liu, HongMei Guang, LiYa Zhu, GuanHua Du, Simon M. Y. Lee & YiTao Wang. (2007) 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Science in China Series C: Life Sciences 50:6, pages 726-730.
Crossref
Crossref
Helen Hudson. (2007) Revised NICE guidance on drugs for Alzheimer's disease and its impact on patients and carers. British Journal of Neuroscience Nursing 3:3, pages 87-91.
Crossref
Crossref
William L. Klein. (2006) Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease. Alzheimer's & Dementia 2:1, pages 43-55.
Crossref
Crossref
David S. Janowsky, John M. Davis & David H. Overstreet. (2005) Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: A potential nerve agent treatment. Pharmacology Biochemistry and Behavior 81:4, pages 917-922.
Crossref
Crossref
Gustavo C. Román. (2005) Cholinergic dysfunction in vascular dementia. Current Psychiatry Reports 7:1, pages 18-26.
Crossref
Crossref
Cristina Paci, Rocco Di Mascio, Roberto Gobbato, Terenzio Carboni, Sandro Sanguigni, Stefania Sobrini, Vittoria Urbano, Federico Olivieri & Luigi Curatola. (2005) Donepezil in Vascular Dementia. Clinical Drug Investigation 25:4, pages 271-276.
Crossref
Crossref
Timo ErkinjunttiGustavo RománSerge GauthierHoward FeldmanKenneth Rockwood. (2004) Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment. Stroke 35:4, pages 1010-1017.
Crossref
Crossref
Cl??ment Fran??ois, Harri Sintonen, Raimo Sulkava & Beno??t Rive. (2004) Cost Effectiveness of Memantine in???Moderately Severe to Severe Alzheimer???s Disease. Clinical Drug Investigation 24:7, pages 373-384.
Crossref
Crossref